Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $3.23 HKD
Change Today 0.00 / 0.00%
Volume 138.0K
853 On Other Exchanges
Hong Kong
As of 4:01 AM 10/9/15 All times are local (Market data is delayed by at least 15 minutes).

microport scientific corp (853) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/14/15 - $4.79
52 Week Low
08/24/15 - $2.63
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MICROPORT SCIENTIFIC CORP (853)

Related News

No related news articles were found.

microport scientific corp (853) Related Businessweek News

No Related Businessweek News Found

microport scientific corp (853) Details

MicroPort Scientific Corporation, an investment holding company, develops, manufactures, exports, and sells interventional medical devices worldwide. Its Orthopedic Devices segment offers orthopedic products of artificial joints, spinal products, trauma products, sport medicine, and other instruments and implants. This segment’s product line includes Superpath micro posterior approach total hip reconstruction technique, Biofoamtm Cancellous Titaniumtm, Evolution medial pivot knee system, Prophecy pre-operative navigation guiding system, and REPIPHYSIS oncology auto-expandable endoprosthesis. The company’s Cardiovascular Devices segment provides coronary stents and related delivery systems; and balloon catheters and accessories. Its Endovascular Devices segment provides AAA/TAA stent graft systems, Hercules balloon dilation catheters, surgical stent graft systems, and peripheral stent systems to treat abdominal and thoracic aortic aneurysms, and peripheral vascular diseases. The company’s Electrophysiological Devices segment offers minimally invasive medical devices, such as FireMagic, EasyFinder, EasyLoop, FireMagic 3D, Columbus, and external reference patch for the treatment of electrophysiological diseases. Its Neurovascular Devices segment provides medical devices to treat the central nervous system related vascular diseases. This segment’s products include WILLIS, an intracranial stent graft system for the treatment of intracranial aneurysms. The company’s Surgical Management segment offers extracorporeal circulation and cardiovascular-related devices, such as membrane oxygenation system, Amender PDA Occluder, and Amender ASD Occluder. Its Diabetes Care and Endocrinal Management segment develops, manufactures, monitors, and manages medical devices, which primarily include La Fenice insulin pump and La Fenice hypophyseal hormone infusion pump for the treatment of diabetes and endocrinal. The company was founded in 1998 and is headquartered in Shanghai, China.

2,892 Employees
Last Reported Date: 09/17/15
Founded in 1998

microport scientific corp (853) Top Compensated Officers

Founder, Chairman of the Board, Chief Executi...
Total Annual Compensation: $98.0K
Compensation as of Fiscal Year 2014.

microport scientific corp (853) Key Developments

MicroPort Scientific Corporation Reports Unaudited Consolidated Cash Flows Results for the Six Months Ended June 30, 2015

MicroPort Scientific Corporation reported unaudited consolidated cash flows results for the six months ended June 30, 2015. For the period, the company reported net cash generated from operating activities of USD 12,255,000 compared to USD 1,939,000 a year ago. Payment for purchase of property, plant and equipment was USD 16,420,000 compared to USD 29,338,000 a year ago.

Microport Scientific Corporation Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2015

MicroPort Scientific Corporation reported unaudited consolidated earnings results for the six months ended June 30, 2015. For the six months, the company reported turnover of USD 191.245 million compared to USD 183.795 million a year ago. Profit from operations was USD 12.672 million compared to USD 0.681 million a year ago. Profit before tax was USD 2.904 million compared to loss before tax of USD 4.391 million a year ago. Loss for the period attributable to equity shareholders of the company was USD 2.961 million or 0.21 cents per diluted share compared to USD 9.943 million or 0.75 cents per diluted share a year ago. For the six months ended 30 June 2015, the Group's total capital expenditure was amounted to approximately USD 21.1 million, which was used in the construction of building; purchase of equipment; and capitalisation of R&D projects expenses. Decrease in net loss was primarily due to the financial performance of both the cardiovascular business and orthopedics business improving for the six months ended 30 June 2015 compared with the six months ended 30 June 2014.

MicroPort Scientific Corporation, H1 2015 Earnings Call, Sep 01, 2015

MicroPort Scientific Corporation, H1 2015 Earnings Call, Sep 01, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
853:HK $3.23 HKD 0.00

853 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ConforMIS Inc $20.62 USD +0.82
Exactech Inc $18.68 USD -0.10
Medtronic PLC $72.60 USD +0.55
Smith & Nephew PLC 1,126 GBp -2.00
View Industry Companies

Industry Analysis


Industry Average

Valuation 853 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.6x
Price/Book 1.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MICROPORT SCIENTIFIC CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at